人ã ãšããªã¢ã«ã«åºäŒãããšãåäŒããããšããããã«å€§åãã身ã«ãã¿ãCOVID-19ãã³ãããã¯ã®çµéšã
ä»åã¯ãã²ãšã€ã²ãšã€ã®åºæ¥äºããšãŠã倧åã«æããŠãã ããæéã®ééãçž«ãã€ã€ã極åãèšé²ãæ®ããŠãããå¿ããããªãããã
æšå€ã¯ããã¥ãŒãºã»ã¯ãªãšã€ã·ã§ã³ãçµæãã2012幎åœåããã¡ã³ããŒã ã£ããã¯ã¯ã€ã¢ïŒããŒã æïŒã®å代ãªãŒããŒæž çŸãããšïŒå¹Žã¶ãããããŠSAREESã®ãŽã¡ã€ãªãªãã¹ãã§ããªãã¿ã®æµçŸåãããšïŒå¹Žåã¶ãã«åäŒïŒãããããäŒãã°æ³æã®æµããäžç¬ã«ããŠé£ãã§ããŸãããã³ã¬ããŒã«ã§ã®æãåºè©±ããããã®åŸã®ããããã®äººçãçŽé¢ããŠãã諞ã ãªã©ãã·ãªã¢ã¹ãªè©±é¡ãå€ãã£ãã¯ããªã®ã«âŠâŠãªãããã¡ãã¡å€§ç¬ãã
幞ããæµçŸåãããéžãã§ããããååŠèª¿å³æäžäœ¿çšãã®ãã«ã·ãŒãªãŽã§ããã æçåºããå šäœçã«è³ããã§å©ãã£ããéããªåºã§ã®åäŒã¯å±éºããããããã«ãæçããŸãéåžžã«ããããã£ããä»åã¯ãã¿ãªããããããã«ããåºã®éžæãèããŠãã ãã£ãŠãããããã
ãã¥ãŒãºã»ã¯ãªãšã€ã·ã§ã³ã§ã¯ãæ¯é±éææ¥ãæŽ»åæ¥ã«ããŠãæå® ããªãŒãã³ããŠã¹ã«ããŠãããéããçµãã£ãåŸãããºãã³ãã®åž°ããæ¯èŒçé ããåäŸãããªã人ãã¡ãæ®ã£ãŠãæŸèª²åŸãã¥ãŒãºããšç§°ããããŒã«ã飲ã¿ã€ã€èªãåãâŠâŠãšããããšããã°ãã°ãã£ãŠãããã¿ããªã§çãäžãã£ãŠãããšãã¢ã«ãŽã£ã³ããåž°ã£ãŠããŠããããããã«åæµãããã®ã ã
ãã£ãŒã¿ã€ã ã®ããã«äœã£ãŠããæäœãã®ãèåãé£ã¹ãªãããæŸèª²åŸã¡ã³ããŒãšèªãåãã®ã楜ããæ§åã ã£ããããããã°ãããã€ãæ®ãå¿ããããã®ãªããçå£ã«æ€æ šããŠãããªâŠâŠç¬
é£äºã®ããšã¯ããã³ããã¿ã³ãªã ãŒãæºç¹ã®æãããã«ã®ã©ãŠã³ãžã«å Žæãç§»ããã¢ã«ã³ãŒã«ã¯æ§ããã«âŠâŠãšæãã€ã€ããç±³åœåšäœæãç¹å¥ãªåºæ¥äºããã£ããšãã«é Œã¿ãã¡ã ã£ããããã£ãŒãããæ³šæãä¹ ãã¶ãã«é£²ãã ãããã£ããé ã£æã£ãŠããŸã£ãããããã¯ããã§ãæ¬åœã«å¿å°ããã
10幎éã®ãã¥ãŒãºã»ã¯ãªãšã€ã·ã§ã³ã®æŽ»åã228åãã®äººã ãšè¡åãå ±ã«ããã«éããŠã¯ããããªãã«çŽäœæ²æããã£ããããããæ¯ãè¿ãã°äœãããããããããã®ãªãçµéšãããããŠä¹ ããä»ãåããåãã«åºäŒããããšããŸãã人çã®å®ã ãšåã«æãã
â¬ïžæ¥æ¬æ ïŒé±éãè©°ã蟌ãã åç»ãã©ãããæ¥œãã¿ãã ããð







ã³ã¡ã³ããæ®ã